Effector Mechanisms in Low‐Dose Streptozotocin‐induced Diabetes
Miodrag L. Lukić(University of Kragujevac), Allen Shahin(United Arab Emirates University), Stanislava Stošić‐Grujičić(University of Belgrade)
Cited by 168
Related Papers
IL-1 family nomenclature
|Nature Immunology|2010|341
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
|International Journal of Cancer|2013|326
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304
Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
|Stem Cells|2010|286
IL-33/ST2 axis in inflammation and immunopathology
|Immunologic Research|2012|259